Global Dermatology OTC Drug Market Size, Status and Forecast 2024-2031

Report ID: 922410 | Published Date: Jan 2025 | No. of Page: 117 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Dermatology OTC Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Antifungals Medication
        1.2.3 Skin Disinfection Medication
        1.2.4 Skin Irritation Medication
        1.2.5 Wounds and Herpes Simplex Medication
        1.2.6 Anti-Psoriasis Medication
        1.2.7 Other
    1.3 Market by Application
        1.3.1 Global Dermatology OTC Drug Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Drug Store
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Dermatology OTC Drug Market Perspective (2016-2027)
    2.2 Dermatology OTC Drug Growth Trends by Regions
        2.2.1 Dermatology OTC Drug Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Dermatology OTC Drug Historic Market Share by Regions (2016-2021)
        2.2.3 Dermatology OTC Drug Forecasted Market Size by Regions (2022-2027)
    2.3 Dermatology OTC Drug Industry Dynamic
        2.3.1 Dermatology OTC Drug Market Trends
        2.3.2 Dermatology OTC Drug Market Drivers
        2.3.3 Dermatology OTC Drug Market Challenges
        2.3.4 Dermatology OTC Drug Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Dermatology OTC Drug Players by Revenue
        3.1.1 Global Top Dermatology OTC Drug Players by Revenue (2016-2021)
        3.1.2 Global Dermatology OTC Drug Revenue Market Share by Players (2016-2021)
    3.2 Global Dermatology OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Dermatology OTC Drug Revenue
    3.4 Global Dermatology OTC Drug Market Concentration Ratio
        3.4.1 Global Dermatology OTC Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Dermatology OTC Drug Revenue in 2020
    3.5 Dermatology OTC Drug Key Players Head office and Area Served
    3.6 Key Players Dermatology OTC Drug Product Solution and Service
    3.7 Date of Enter into Dermatology OTC Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Dermatology OTC Drug Breakdown Data by Type
    4.1 Global Dermatology OTC Drug Historic Market Size by Type (2016-2021)
    4.2 Global Dermatology OTC Drug Forecasted Market Size by Type (2022-2027)

5 Dermatology OTC Drug Breakdown Data by Application
    5.1 Global Dermatology OTC Drug Historic Market Size by Application (2016-2021)
    5.2 Global Dermatology OTC Drug Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Dermatology OTC Drug Market Size (2016-2027)
    6.2 North America Dermatology OTC Drug Market Size by Type
        6.2.1 North America Dermatology OTC Drug Market Size by Type (2016-2021)
        6.2.2 North America Dermatology OTC Drug Market Size by Type (2022-2027)
        6.2.3 North America Dermatology OTC Drug Market Size by Type (2016-2027)
    6.3 North America Dermatology OTC Drug Market Size by Application
        6.3.1 North America Dermatology OTC Drug Market Size by Application (2016-2021)
        6.3.2 North America Dermatology OTC Drug Market Size by Application (2022-2027)
        6.3.3 North America Dermatology OTC Drug Market Size by Application (2016-2027)
    6.4 North America Dermatology OTC Drug Market Size by Country
        6.4.1 North America Dermatology OTC Drug Market Size by Country (2016-2021)
        6.4.2 North America Dermatology OTC Drug Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Dermatology OTC Drug Market Size (2016-2027)
    7.2 Europe Dermatology OTC Drug Market Size by Type
        7.2.1 Europe Dermatology OTC Drug Market Size by Type (2016-2021)
        7.2.2 Europe Dermatology OTC Drug Market Size by Type (2022-2027)
        7.2.3 Europe Dermatology OTC Drug Market Size by Type (2016-2027)
    7.3 Europe Dermatology OTC Drug Market Size by Application
        7.3.1 Europe Dermatology OTC Drug Market Size by Application (2016-2021)
        7.3.2 Europe Dermatology OTC Drug Market Size by Application (2022-2027)
        7.3.3 Europe Dermatology OTC Drug Market Size by Application (2016-2027)
    7.4 Europe Dermatology OTC Drug Market Size by Country
        7.4.1 Europe Dermatology OTC Drug Market Size by Country (2016-2021)
        7.4.2 Europe Dermatology OTC Drug Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Dermatology OTC Drug Market Size (2016-2027)
    8.2 Asia-Pacific Dermatology OTC Drug Market Size by Type
        8.2.1 Asia-Pacific Dermatology OTC Drug Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Dermatology OTC Drug Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Dermatology OTC Drug Market Size by Type (2016-2027)
    8.3 Asia-Pacific Dermatology OTC Drug Market Size by Application
        8.3.1 Asia-Pacific Dermatology OTC Drug Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Dermatology OTC Drug Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Dermatology OTC Drug Market Size by Application (2016-2027)
    8.4 Asia-Pacific Dermatology OTC Drug Market Size by Region
        8.4.1 Asia-Pacific Dermatology OTC Drug Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Dermatology OTC Drug Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Dermatology OTC Drug Market Size (2016-2027)
    9.2 Latin America Dermatology OTC Drug Market Size by Type
        9.2.1 Latin America Dermatology OTC Drug Market Size by Type (2016-2021)
        9.2.2 Latin America Dermatology OTC Drug Market Size by Type (2022-2027)
        9.2.3 Latin America Dermatology OTC Drug Market Size by Type (2016-2027)
    9.3 Latin America Dermatology OTC Drug Market Size by Application
        9.3.1 Latin America Dermatology OTC Drug Market Size by Application (2016-2021)
        9.3.2 Latin America Dermatology OTC Drug Market Size by Application (2022-2027)
        9.3.3 Latin America Dermatology OTC Drug Market Size by Application (2016-2027)
    9.4 Latin America Dermatology OTC Drug Market Size by Country
        9.4.1 Latin America Dermatology OTC Drug Market Size by Country (2016-2021)
        9.4.2 Latin America Dermatology OTC Drug Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Dermatology OTC Drug Market Size (2016-2027)
    10.2 Middle East & Africa Dermatology OTC Drug Market Size by Type
        10.2.1 Middle East & Africa Dermatology OTC Drug Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Dermatology OTC Drug Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Dermatology OTC Drug Market Size by Type (2016-2027)
    10.3 Middle East & Africa Dermatology OTC Drug Market Size by Application
        10.3.1 Middle East & Africa Dermatology OTC Drug Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Dermatology OTC Drug Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Dermatology OTC Drug Market Size by Application (2016-2027)
    10.4 Middle East & Africa Dermatology OTC Drug Market Size by Country
        10.4.1 Middle East & Africa Dermatology OTC Drug Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Dermatology OTC Drug Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Details
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Dermatology OTC Drug Introduction
        11.1.4 Bayer Revenue in Dermatology OTC Drug Business (2016-2021)
        11.1.5 Bayer Recent Development
    11.2 GSK
        11.2.1 GSK Company Details
        11.2.2 GSK Business Overview
        11.2.3 GSK Dermatology OTC Drug Introduction
        11.2.4 GSK Revenue in Dermatology OTC Drug Business (2016-2021)
        11.2.5 GSK Recent Development
    11.3 Teva
        11.3.1 Teva Company Details
        11.3.2 Teva Business Overview
        11.3.3 Teva Dermatology OTC Drug Introduction
        11.3.4 Teva Revenue in Dermatology OTC Drug Business (2016-2021)
        11.3.5 Teva Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Dermatology OTC Drug Introduction
        11.4.4 Johnson & Johnson Revenue in Dermatology OTC Drug Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Dermatology OTC Drug Introduction
        11.5.4 Novartis Revenue in Dermatology OTC Drug Business (2016-2021)
        11.5.5 Novartis Recent Development
    11.6 Mylan
        11.6.1 Mylan Company Details
        11.6.2 Mylan Business Overview
        11.6.3 Mylan Dermatology OTC Drug Introduction
        11.6.4 Mylan Revenue in Dermatology OTC Drug Business (2016-2021)
        11.6.5 Mylan Recent Development
    11.7 Sun Pharmaceutical
        11.7.1 Sun Pharmaceutical Company Details
        11.7.2 Sun Pharmaceutical Business Overview
        11.7.3 Sun Pharmaceutical Dermatology OTC Drug Introduction
        11.7.4 Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2016-2021)
        11.7.5 Sun Pharmaceutical Recent Development
    11.8 Aurobindo
        11.8.1 Aurobindo Company Details
        11.8.2 Aurobindo Business Overview
        11.8.3 Aurobindo Dermatology OTC Drug Introduction
        11.8.4 Aurobindo Revenue in Dermatology OTC Drug Business (2016-2021)
        11.8.5 Aurobindo Recent Development
    11.9 Galderma
        11.9.1 Galderma Company Details
        11.9.2 Galderma Business Overview
        11.9.3 Galderma Dermatology OTC Drug Introduction
        11.9.4 Galderma Revenue in Dermatology OTC Drug Business (2016-2021)
        11.9.5 Galderma Recent Development
    11.10 CR SANJIU
        11.10.1 CR SANJIU Company Details
        11.10.2 CR SANJIU Business Overview
        11.10.3 CR SANJIU Dermatology OTC Drug Introduction
        11.10.4 CR SANJIU Revenue in Dermatology OTC Drug Business (2016-2021)
        11.10.5 CR SANJIU Recent Development
    11.11 Dr. Reddy's
        11.11.1 Dr. Reddy's Company Details
        11.11.2 Dr. Reddy's Business Overview
        11.11.3 Dr. Reddy's Dermatology OTC Drug Introduction
        11.11.4 Dr. Reddy's Revenue in Dermatology OTC Drug Business (2016-2021)
        11.11.5 Dr. Reddy's Recent Development
    11.12 Lupin
        11.12.1 Lupin Company Details
        11.12.2 Lupin Business Overview
        11.12.3 Lupin Dermatology OTC Drug Introduction
        11.12.4 Lupin Revenue in Dermatology OTC Drug Business (2016-2021)
        11.12.5 Lupin Recent Development
    11.13 Bausch Health
        11.13.1 Bausch Health Company Details
        11.13.2 Bausch Health Business Overview
        11.13.3 Bausch Health Dermatology OTC Drug Introduction
        11.13.4 Bausch Health Revenue in Dermatology OTC Drug Business (2016-2021)
        11.13.5 Bausch Health Recent Development
    11.14 Cipla
        11.14.1 Cipla Company Details
        11.14.2 Cipla Business Overview
        11.14.3 Cipla Dermatology OTC Drug Introduction
        11.14.4 Cipla Revenue in Dermatology OTC Drug Business (2016-2021)
        11.14.5 Cipla Recent Development
    11.15 Livzon
        11.15.1 Livzon Company Details
        11.15.2 Livzon Business Overview
        11.15.3 Livzon Dermatology OTC Drug Introduction
        11.15.4 Livzon Revenue in Dermatology OTC Drug Business (2016-2021)
        11.15.5 Livzon Recent Development
    11.16 Almirall
        11.16.1 Almirall Company Details
        11.16.2 Almirall Business Overview
        11.16.3 Almirall Dermatology OTC Drug Introduction
        11.16.4 Almirall Revenue in Dermatology OTC Drug Business (2016-2021)
        11.16.5 Almirall Recent Development
    11.17 Lingrui
        11.17.1 Lingrui Company Details
        11.17.2 Lingrui Business Overview
        11.17.3 Lingrui Dermatology OTC Drug Introduction
        11.17.4 Lingrui Revenue in Dermatology OTC Drug Business (2016-2021)
        11.17.5 Lingrui Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Dermatology OTC Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Antifungals Medication
    Table 3. Key Players of Skin Disinfection Medication
    Table 4. Key Players of Skin Irritation Medication
    Table 5. Key Players of Wounds and Herpes Simplex Medication
    Table 6. Key Players of Anti-Psoriasis Medication
    Table 7. Key Players of Other
    Table 8. Global Dermatology OTC Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Dermatology OTC Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Dermatology OTC Drug Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Dermatology OTC Drug Market Share by Regions (2016-2021)
    Table 12. Global Dermatology OTC Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Dermatology OTC Drug Market Share by Regions (2022-2027)
    Table 14. Dermatology OTC Drug Market Trends
    Table 15. Dermatology OTC Drug Market Drivers
    Table 16. Dermatology OTC Drug Market Challenges
    Table 17. Dermatology OTC Drug Market Restraints
    Table 18. Global Dermatology OTC Drug Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Dermatology OTC Drug Market Share by Players (2016-2021)
    Table 20. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Drug as of 2020)
    Table 21. Ranking of Global Top Dermatology OTC Drug Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Dermatology OTC Drug Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Dermatology OTC Drug Product Solution and Service
    Table 25. Date of Enter into Dermatology OTC Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Dermatology OTC Drug Revenue Market Share by Type (2016-2021)
    Table 29. Global Dermatology OTC Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Dermatology OTC Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Dermatology OTC Drug Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Dermatology OTC Drug Revenue Market Share by Application (2016-2021)
    Table 33. Global Dermatology OTC Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Dermatology OTC Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Dermatology OTC Drug Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Dermatology OTC Drug Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Dermatology OTC Drug Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Dermatology OTC Drug Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Dermatology OTC Drug Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Dermatology OTC Drug Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Dermatology OTC Drug Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Dermatology OTC Drug Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. Bayer Company Details
    Table 66. Bayer Business Overview
    Table 67. Bayer Dermatology OTC Drug Product
    Table 68. Bayer Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 69. Bayer Recent Development
    Table 70. GSK Company Details
    Table 71. GSK Business Overview
    Table 72. GSK Dermatology OTC Drug Product
    Table 73. GSK Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 74. GSK Recent Development
    Table 75. Teva Company Details
    Table 76. Teva Business Overview
    Table 77. Teva Dermatology OTC Drug Product
    Table 78. Teva Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 79. Teva Recent Development
    Table 80. Johnson & Johnson Company Details
    Table 81. Johnson & Johnson Business Overview
    Table 82. Johnson & Johnson Dermatology OTC Drug Product
    Table 83. Johnson & Johnson Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 84. Johnson & Johnson Recent Development
    Table 85. Novartis Company Details
    Table 86. Novartis Business Overview
    Table 87. Novartis Dermatology OTC Drug Product
    Table 88. Novartis Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 89. Novartis Recent Development
    Table 90. Mylan Company Details
    Table 91. Mylan Business Overview
    Table 92. Mylan Dermatology OTC Drug Product
    Table 93. Mylan Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 94. Mylan Recent Development
    Table 95. Sun Pharmaceutical Company Details
    Table 96. Sun Pharmaceutical Business Overview
    Table 97. Sun Pharmaceutical Dermatology OTC Drug Product
    Table 98. Sun Pharmaceutical Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 99. Sun Pharmaceutical Recent Development
    Table 100. Aurobindo Company Details
    Table 101. Aurobindo Business Overview
    Table 102. Aurobindo Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 103. Aurobindo Recent Development
    Table 104. Galderma Company Details
    Table 105. Galderma Business Overview
    Table 106. Galderma Dermatology OTC Drug Product
    Table 107. Galderma Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 108. Galderma Recent Development
    Table 109. CR SANJIU Company Details
    Table 110. CR SANJIU Business Overview
    Table 111. CR SANJIU Dermatology OTC Drug Product
    Table 112. CR SANJIU Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 113. CR SANJIU Recent Development
    Table 114. Dr. Reddy's Company Details
    Table 115. Dr. Reddy's Business Overview
    Table 116. Dr. Reddy's Dermatology OTC Drug Product
    Table 117. Dr. Reddy's Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 118. Dr. Reddy's Recent Development
    Table 119. Lupin Company Details
    Table 120. Lupin Business Overview
    Table 121. Lupin Dermatology OTC Drug Product
    Table 122. Lupin Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 123. Lupin Recent Development
    Table 124. Bausch Health Company Details
    Table 125. Bausch Health Business Overview
    Table 126. Bausch Health Dermatology OTC Drug Product
    Table 127. Bausch Health Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 128. Bausch Health Recent Development
    Table 129. Cipla Company Details
    Table 130. Cipla Business Overview
    Table 131. Cipla Dermatology OTC Drug Product
    Table 132. Cipla Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 133. Cipla Recent Development
    Table 134. Livzon Company Details
    Table 135. Livzon Business Overview
    Table 136. Livzon Dermatology OTC Drug Product
    Table 137. Livzon Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 138. Livzon Recent Development
    Table 139. Almirall Company Details
    Table 140. Almirall Business Overview
    Table 141. Almirall Dermatology OTC Drug Product
    Table 142. Almirall Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 143. Almirall Recent Development
    Table 144. Lingrui Company Details
    Table 145. Lingrui Business Overview
    Table 146. Lingrui Dermatology OTC Drug Product
    Table 147. Lingrui Revenue in Dermatology OTC Drug Business (2016-2021) & (US$ Million)
    Table 148. Lingrui Recent Development
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dermatology OTC Drug Market Share by Type: 2020 VS 2027
    Figure 2. Antifungals Medication Features
    Figure 3. Skin Disinfection Medication Features
    Figure 4. Skin Irritation Medication Features
    Figure 5. Wounds and Herpes Simplex Medication Features
    Figure 6. Anti-Psoriasis Medication Features
    Figure 7. Other Features
    Figure 8. Global Dermatology OTC Drug Market Share by Application: 2020 VS 2027
    Figure 9. Hospital Case Studies
    Figure 10. Drug Store Case Studies
    Figure 11. Other Case Studies
    Figure 12. Dermatology OTC Drug Report Years Considered
    Figure 13. Global Dermatology OTC Drug Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Dermatology OTC Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Dermatology OTC Drug Market Share by Regions: 2020 VS 2027
    Figure 16. Global Dermatology OTC Drug Market Share by Regions (2022-2027)
    Figure 17. Global Dermatology OTC Drug Market Share by Players in 2020
    Figure 18. Global Top Dermatology OTC Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Drug as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Dermatology OTC Drug Revenue in 2020
    Figure 20. Global Dermatology OTC Drug Revenue Market Share by Type (2016-2021)
    Figure 21. Global Dermatology OTC Drug Revenue Market Share by Type (2022-2027)
    Figure 22. North America Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Dermatology OTC Drug Market Share by Type (2016-2027)
    Figure 24. North America Dermatology OTC Drug Market Share by Application (2016-2027)
    Figure 25. North America Dermatology OTC Drug Market Share by Country (2016-2027)
    Figure 26. United States Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Dermatology OTC Drug Market Share by Type (2016-2027)
    Figure 30. Europe Dermatology OTC Drug Market Share by Application (2016-2027)
    Figure 31. Europe Dermatology OTC Drug Market Share by Country (2016-2027)
    Figure 32. Germany Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Dermatology OTC Drug Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Dermatology OTC Drug Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Dermatology OTC Drug Market Share by Region (2016-2027)
    Figure 42. China Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Dermatology OTC Drug Market Share by Type (2016-2027)
    Figure 50. Latin America Dermatology OTC Drug Market Share by Application (2016-2027)
    Figure 51. Latin America Dermatology OTC Drug Market Share by Country (2016-2027)
    Figure 52. Mexico Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Dermatology OTC Drug Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Dermatology OTC Drug Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Dermatology OTC Drug Market Share by Country (2016-2027)
    Figure 58. Turkey Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Dermatology OTC Drug Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Bayer Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 62. GSK Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 63. Teva Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 65. Novartis Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 66. Mylan Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 67. Sun Pharmaceutical Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 68. Aurobindo Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 69. Galderma Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 70. CR SANJIU Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 71. Dr. Reddy's Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 72. Lupin Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 73. Bausch Health Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 74. Cipla Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 75. Livzon Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 76. Almirall Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 77. Lingrui Revenue Growth Rate in Dermatology OTC Drug Business (2016-2021)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Livzon
Almirall
Lingrui
Frequently Asked Questions
Dermatology OTC Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dermatology OTC Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dermatology OTC Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Wound Closure

Wound closure is the final step of surgical intervention. There are two major types of wound cl ... Read More